Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies.

ABSTRACT:

Background

Dengue is the most prevalent arthropod-borne viral human disease in tropical and subtropical regions, caused by four dengue virus (DENV) serotypes. In spite of the increasing global incidence, no specific antiviral therapy is available. Cells of the mononuclear phagocyte lineage are the main targets either for direct antibody (Ab)-independent or Ab-mediated human DENV infection, usually associated to the severe forms of disease. Since the virus entry may be a convenient therapeutic alternative, this study aimed to investigate the mode of DENV internalization into myeloid cells in the absence and presence of DENV Ab and evaluate the inhibitory activity of diverse biochemical inhibitors of endocytosis.

Methodology/principal findings

By infectivity assays and quantit

SUBMITTER: Carro AC 

PROVIDER: S-EPMC6103515 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature